NDUFA4 Mutations Underlie Dysfunction of a Cytochrome c Oxidase Subunit Linked to Human Neurological Disease
Robert D.S. Pitceathly,
Shamima Rahman,
Yehani Wedatilake,
James M. Polke,
Sebahattin Cirak,
A. Reghan Foley,
Anna Sailer,
Matthew E. Hurles,
Jim Stalker,
Iain Hargreaves,
Cathy E. Woodward,
Mary G. Sweeney,
Francesco Muntoni,
Henry Houlden,
Jan-Willem Taanman,
Michael G. Hanna
Affiliations
Robert D.S. Pitceathly
MRC Centre for Neuromuscular Diseases, UCL Institute of Neurology and National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK
Shamima Rahman
MRC Centre for Neuromuscular Diseases, UCL Institute of Neurology and National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK
Yehani Wedatilake
Mitochondrial Research Group, Clinical and Molecular Genetics Unit, UCL Institute of Child Health, London WC1N 1EH, UK
James M. Polke
Neurogenetics Unit, National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK
Sebahattin Cirak
Dubowitz Neuromuscular Centre, UCL Institute of Child Health and Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 1EH, UK
A. Reghan Foley
Dubowitz Neuromuscular Centre, UCL Institute of Child Health and Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 1EH, UK
Anna Sailer
Department of Molecular Neuroscience, UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK
Matthew E. Hurles
The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, UK
Jim Stalker
The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, UK
Iain Hargreaves
Neurometabolic Unit, National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK
Cathy E. Woodward
Neurogenetics Unit, National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK
Mary G. Sweeney
Neurogenetics Unit, National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK
Francesco Muntoni
Dubowitz Neuromuscular Centre, UCL Institute of Child Health and Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 1EH, UK
Henry Houlden
MRC Centre for Neuromuscular Diseases, UCL Institute of Neurology and National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK
Jan-Willem Taanman
Department of Clinical Neuroscience, UCL Institute of Neurology, London NW3 2PF, UK
Michael G. Hanna
MRC Centre for Neuromuscular Diseases, UCL Institute of Neurology and National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK
The molecular basis of cytochrome c oxidase (COX, complex IV) deficiency remains genetically undetermined in many cases. Homozygosity mapping and whole-exome sequencing were performed in a consanguineous pedigree with isolated COX deficiency linked to a Leigh syndrome neurological phenotype. Unexpectedly, affected individuals harbored homozygous splice donor site mutations in NDUFA4, a gene previously assigned to encode a mitochondrial respiratory chain complex I (NADH:ubiquinone oxidoreductase) subunit. Western blot analysis of denaturing gels and immunocytochemistry revealed undetectable steady-state NDUFA4 protein levels, indicating that the mutation causes a loss-of-function effect in the homozygous state. Analysis of one- and two-dimensional blue-native polyacrylamide gels confirmed an interaction between NDUFA4 and the COX enzyme complex in control muscle, whereas the COX enzyme complex without NDUFA4 was detectable with no abnormal subassemblies in patient muscle. These observations support recent work in cell lines suggesting that NDUFA4 is an additional COX subunit and demonstrate that NDUFA4 mutations cause human disease. Our findings support reassignment of the NDUFA4 protein to complex IV and suggest that patients with unexplained COX deficiency should be screened for NDUFA4 mutations.